The expanded access cure : a twenty-first century framework for companies
Year of publication: |
2019
|
---|---|
Authors: | Lee, Stacey B. ; Murata, Alexandra Y. |
Published in: |
Journal of business ethics : JOBE. - Dordrecht : Springer, ISSN 0167-4544, ZDB-ID 868017-6. - Vol. 156.2019, 1, p. 155-171
|
Subject: | Expanded access | Compassionate use | Corporate frameworks | Experimental drugs | Investigational drugs | FDA | Pharmaceutical manufacturers | Resource allocation | Arzneimittel | Pharmaceuticals | Pharmaindustrie | Pharmaceutical industry | Arzneimittelrecht | Pharmaceutical law |
-
The Friday effect : firm lobbying, the timing of drug safety alerts, and drug side effects
Diestre, Luis, (2020)
-
FDA approval announcements : attention-grabbing or event-day misspecification?
Hamill, Philip, (2018)
-
Miller, Kathleen L., (2018)
- More ...
-
Generic Manufacturers' Labeling Catch-22
Lee, Stacey B., (2013)
-
Pliva v. Mensing : Generic Consumers' Unfortunate Hand
Lee, Stacey B., (2012)
-
Is a Cure on the Way? The Bad Medicine of Generics, Citizen Petitions and Noerr-Pennington Immunity
Lee, Stacey B., (2012)
- More ...